Nutrition, supplements, and vitamins in platelet function and bleeding

Circulation

Volumn 121, Issue 8, 2010, Pages 1033-1044

  Violi, Francesco ^a   Pignatelli, Pasquale ^a   Basili, Stefania ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CD40 LIGAND; DOCOSAHEXAENOIC ACID; FLAVANOL DERIVATIVE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; NITRIC OXIDE; OLIVE OIL; PADGEM PROTEIN; POLYPHENOL DERIVATIVE; PYRIDOXINE; SELENIUM; THROMBOXANE B2;

ABSENCE OF SIDE EFFECTS; ANTICOAGULATION; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CACAO; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DRUG MECHANISM; GRAPE JUICE; HEART INFARCTION; HUMAN; MEDITERRANEAN DIET; NONHUMAN; NUTRITION; ORANGE JUICE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; TREATMENT DURATION; WINE;

ATHEROSCLEROSIS; BLOOD PLATELETS; DIETARY SUPPLEMENTS; HEMORRHAGE; HUMANS; NUTRITION THERAPY; PLATELET AGGREGATION INHIBITORS; VITAMINS;

EID: 77649258315     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.880211     Document Type: Review

References (145)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232-235.
2. Cattaneo M. Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol. 2004;24:1980-1987.
3. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
4. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo-cardial infarction, and stroke in high risk patients. BMJ. 2002;324: 71-86.
5. Cotter G, Shemesh E, Zehavi M, Dinur I, Rudnick A, Milo O, Vered Z, Krakover R, Kaluski E, Kornberg A. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J. 2004;147: 293-300.
6. Pignatelli P, Di Santo S, Barillà F, Gaudio C, Violi F. Multiple anti-atherosclerotic treatments impair aspirin compliance: effects on aspirin resistance. J Thromb Haemost. 2008;6:1832-1834.
7. Violi F, Pignatelli P. Aspirin resistance: is this term meaningful? Curr Opin Hematol. 2006;13:331-336.
8. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM, for the TRITON-TIMI 38 Investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009;373:723-731.
9. Yancy WS Jr, Westman EC, French PA, Califf RM. Diets and clinical coronary events: the truth is out there. Circulation. 2003;107:10-16.
10. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599-2608.
11. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr. 2006;136:2588-2593.
12. Lee KW, Lip GY. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM. 2003;96:465-480.
13. Keys A, Aravanis C, Blackburn HW, Van Buchem FS, Buzina R, Djordjevíc BD, Dontas AS, Fidanza F, Karvonen MJ, Kimura N, Lekos D, Monti M, Puddu V, Taylor HL. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl. 1966;460:1-392.
14. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008;337: a1344. Abstract.
15. Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation. 2009;119:1093-1100.
16. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779-785.
17. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Colditz G, Ascherio A, Rosner B, Spiegelman D, Willett WC. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001;134:1106-1114.
18. Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S, Niaz MA. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ. 1992;304:1015-1019.
19. Feskens EJ, Kromhout D. Epidemiologic studies on Eskimos and fish intake. Ann N Y Acad Sci. 1993;683:9-15.
20. Whelton SP, He J, Whelton PK, Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol. 2004;93:1119-1123.
21. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-1118. (Pubitemid 34984601)
22. Campos H, Baylin A, Willett WC. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation. 2008;118:339-345.
23. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659-669.
24. Mezzano D, Leighton F, Strobel P, Martínez C, Marshall G, Cuevas A, Castillo O, Panes O, Muñoz B, Rozowski J, Pereira J. Mediterranean diet, but not red wine, is associated with beneficial changes in primary haemostasis. Eur J Clin Nutr. 2003;57:439-446.
25. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsat-urated fatty acids in Eskimos. Lancet. 1979;2:433-435.
26. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial: Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-455.
27. Marckmann P, Gronbaek M. Fish consumption and coronary heart disease mortality: a systematic review of prospective cohort studies. Eur J Clin Nutr. 1999;53:585-590.
28. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 1997; 17:279-286.
29. Agren JJ, Väisänen S, Hänninen O, Muller AD, Hornstra G. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids. 1997;57:419-421.
30. Pirich C, Gaszo A, Granegger S, Sinzinger H. Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hyper-cholesterolemic patients. Thromb Res. 1999;96:219-227.
31. Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic acid and docosa-hexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis. 2003;166:85-93.
32. Aarsetøy H, Brügger-Andersen T, Hetland Ø, Grundt H, Nilsen DW. Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction. Thromb Haemost. 2006;95:329-336.
33. Larson MK, Ashmore JH, Harris KA, Vogelaar JL, Pottala JV, Sprehe M, Harris WS. Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb Haemost. 2008;100:634-641.
34. Din JN, Harding SA, Valerio CJ, Sarma J, Lyall K, Riemersma RA, Newby DE, Flapan AD. Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis. 2008;197: 290-296.
35. Freese R, Mutanen M. Alpha-linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. Am J Clin Nutr. 1997;66:591-598.
36. Kwon JS, Snook JT, Wardlaw GM, Hwang DH. Effects of diets high in saturated fatty acids, canola oil, or safflower oil on platelet function, thromboxane B2 formation, and fatty acid composition of platelet phos-pholipids. Am J Clin Nutr. 1991;54:351-358.
37. Freese R, Mutanen M, Valsta LM, Salminen I. Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation. Thromb Haemost. 1994;71:73-77.
38. Allman MA, Pena MM, Pang D. Supplementation with flaxseed oil versus sunflowerseed oil in healthy young men consuming a low fat diet: effects on platelet composition and function. Eur J Clin Nutr. 1995;49: 169-178.
39. Armstrong RA, Chardigny JM, Beaufrère B, Bretillon L, Vermunt SH, Mensink RP, Macvean A, Elton RA, Sébédio JL, Riemersma RA. No effect of dietary trans isomers of alpha-linolenic acid on platelet aggregation and haemostatic factors in European healthy men: the TRANSLinE study. Thromb Res. 2000;100:133-141.
40. Ghafoorunissa, Vani A, Laxmi R, Sesikeran B. Effects of dietary alpha-linolenic acid from blended oils on biochemical indices of coronary heart disease in Indians. Lipids. 2002;37:1077-1086.
41. Alessandri C, Pignatelli P, Loffredo L, Lenti L, Del Ben M, Carnevale R, Perrone A, Ferro D, Angelico F, Violi F. Alpha-linolenic acid-rich wheat germ oil decreases oxidative stress and CD40 ligand in patients with mild hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2006; 26:2577-2578.
42. Clark WF, Parbtani A, Huff MW, Spanner E, de Salis H, Chin-Yee I, Philbrick DJ, Holub BJ. Flaxseed: a potential treatment for lupus nephritis. Kidney Int. 1995;48:475-480.
43. Medini L, Colli S, Mosconi C, Tremoli E, Galli C. Diets rich in n-9, n-6 and n-3 fatty acids differentially affect the generation of inositol phosphates and of thromboxane by stimulated platelets, in the rabbit. Biochem Pharmacol. 1990;39:129-133.
44. Urakaze M, Hamazaki T, Makuta M, Ibuki F, Kobayashi S, Yano S, Kumagai A. Infusion of fish oil emulsion: effects on platelet aggregation and fatty acid composition in phospholipids of plasma, platelets, and red blood cell membranes in rabbits. Am J Clin Nutr. 1987;46:936-940.
45. Lichtenstein AH, Chobanian AV. Effect of fish oil on atherogenesis in Watanabe heritable hyperlipidemic rabbit. Arteriosclerosis. 1990;10: 597-606.
46. Thorwest M, Balling E, Kristensen SD, Aagaard S, Hakami A, Husted SE, Marqversen J, Hjortdal VE. Dietary fish oil reduces microvascular thrombosis in a porcine experimental model. Thromb Res. 2000;99: 203-208.
47. Jerling JC, Curiel-Martos A, Kroner C, Kloots W. Fish oil inhibits photochemically induced thrombosis in the guinea pig in a dose dependent manner. Thromb Res. 2003;111:11-17.
48. Kinsella JE, Lokesh B, Stone RA. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr. 1990;52:1-28.
49. Sirtori CR, Tremoli E, Gatti E, Montanari G, Sirtori M, Colli S, Gian-franceschi G, Maderna P, Dentone CZ, Testolin G, Gaii C. Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients. Am J Clin Nutr. 1986;44:635-642.
50. Junker R, Kratz M, Neufeld M, Erren M, Nofer JR, Schulte H, Nowak-Göttl U, Assmann G, Wahrburg U. Effects of diets containing olive oil, sunflower oil, or rapeseed oil on the hemostatic system. Thromb Haemost. 2001;85:280-286. (Pubitemid 32140574)
51. Vicario IM, Malkova D, Lund EK, Johnson IT. Olive oil supplementation in healthy adults: effects in cell membrane fatty acid composition and platelet function. Ann Nutr Metab. 1998;42:160-169.
52. Léger CL, Carbonneau MA, Michel F, Mas E, Monnier L, Cristol JP, Descomps B. A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. Eur J Clin Nutr. 2005;59:727-730.
53. Kelly CM, Smith RD, Williams CM. Dietary monounsaturated fatty acids and haemostasis. Proc Nutr Soc. 2001;60:161-170.
54. Smith RD, Kelly CN, Fielding BA, Hauton D, Silva KD, Nydahl MC, Miller GJ, Williams CM. Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjects. Br J Nutr. 2003; 90:597-606.
55. Temme EH, Mensink RP, Hornstra G. Individual saturated fatty acids and effects on whole blood aggregation in vitro. Eur J Clin Nutr. 1998;52:697-702.
56. Turpeinen AM, Pajari AM, Freese R, Sauer R, Mutanen M. Replacement of dietary saturated by unsaturated fatty acids: effects of platelet protein kinase C activity, urinary content of 2,3-dinor-TXB2 and in vitro platelet aggregation in healthy man. Thromb Haemost. 1998;80: 649-655.
57. Misikangas M, Freese R, Turpeinen AM, Mutanen M. High linoleic acid, low vegetable, and high oleic acid, high vegetable diets affect platelet activation similarly in healthy women and men. J Nutr. 2001; 131:1700-1705.
58. Thijssen MA, Hornstra G, Mensink RP. Stearic, oleic, and linoleic acids have comparable effects on markers of thrombotic tendency in healthy human subjects. J Nutr. 2005;135:2805-2811.
59. Lahoz C, Alonso R, Ordovás JM, López-Farré A, de Oya M, Mata P. Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur J Clin Invest. 1997;27:780-787.
60. Grønbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO, Jensen G, Sørensen TI. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med. 2000;13: 411-419.
61. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, De Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation. 2002;105:2836-2844.
62. Nielsen NR, Schnohr P, Jensen G, Gronbaek M. Is the relationship between type of alcohol and mortality influenced by socio-economic status? J Int Med. 2004;255:280-288.
63. Renaud SC, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr. 1992;55:1012-1017.
64. Numminen H, Kobayashi M, Uchiyama S, Iwata M, Ikeda Y, Riutta A, Syrjälä M, Kekomäki R, Hillbom M. Effects of alcohol and the evening meal on shear-induced platelet aggregation and urinary excretion of prostanoids. Alcohol Alcohol. 2000;35:594-600.
65. Kikura M, Levy JH, Safon RA, Lee MK, Szlam F. The influence of red wine or white wine intake on platelet function and viscoelastic property of blood in volunteers. Platelets. 2004;15:37-41.
66. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta. 1996;246:163-182.
67. Mansvelt EP, van Velden DP, Fourie E, Rossouw M, van Rensburg SJ, Smuts CM. The in vivo antithrombotic effect of wine consumption on human blood platelets and hemostatic factors. Ann N Y Acad Sci. 2002; 957:329-332.
68. Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma AM, Ghiselli A, Momi S, Violi F. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr. 2008;138:1602-1608.
69. Pignatelli P, Lenti L, Pulcinelli FM, Catasca R, Saccani G, Germanò G, Marcoccia A, Silvestri MA, Ghiselli A, Violi F. Red and white wine differently affect collagen-induced platelet aggregation. Pathophysiol Haemost Thromb. 2002;32:356-358.
70. Miceli M, Alberti L, Bennardini F, Di Simplicio P, Seghieri G, Rao GH, Franconi F. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers. Life Sci. 2003;73: 1557-1566.
71. Pellegrini N, Pareti FI, Stabile F, Brusamolino A, Simonetti P. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr. 1996;50: 209-213. (Pubitemid 26123946)
72. Rein D, Paglieroni TG, Pearson DA, Wun T, Schmitz HH, Gosselin R, Keen CL. Cocoa and wine polyphenols modulate platelet activation and function. J Nutr. 2000;130:2120S-2126S.
73. Wollny T, Aiello L, Di Tommaso D, Bellavia V, Rotilio D, Donati MB, de Gaetano G, Iacoviello L. Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production. Br J Pharmacol. 1999;127:747-755.
74. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 1995;91:1182-1188.
75. Leifert WR, Abeywardena MY. Cardioprotective actions of grape poly-phenols. Nutr Res. 2008;28:729-737.
76. Keevil JG, Osman HE, Reed JD, Folts JD. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr. 2000;130:53-56.
77. Freedman JE, Parker C III, Li L, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD, Folts JD. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation. 2001;103:2792-2798.
78. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000;71:1062-1076.
79. Freese R, Vaarala O, Turpeinen AM, Mutanen M. No difference in platelet activation or inflammation markers after diets rich or poor in vegetables, berries and apple in healthy subjects. Eur J Nutr. 2004;43: 175-182.
80. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, Mattila P, Jula A. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008;87:323-331.
81. Rein D, Paglieroni TG, Wun T, Pearson DA, Schmitz HH, Gosselin R, Keen CL. Cocoa inhibits platelet activation and function. Am J Clin Nutr. 2000;72:30-35.
82. Pearson DA, Paglieroni TG, Rein D, Wun T, Schramm DD, Wang JF, Holt RR, Gosselin R, Schmitz HH, Keen CL. The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res. 2002;106:191-197.
83. Innes AJ, Kennedy G, McLaren M, Bancroft AJ, Belch JJ. Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets. 2003;14:325-327.
84. Murphy KJ, Chronopoulos AK, Singh I, Francis MA, Moriarty H, Pike MJ, Turner AH, Mann NJ, Sinclair AJ. Dietary flavanols and pro-cyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr. 2003;77:1466-1473.
85. Heptinstall S, May J, Fox S, Kwik-Uribe C, Zhao L. Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults. J Cardiovasc Pharmacol. 2006;47:S197-S205.
86. Wang-Polagruto JF, Villablanca AC, Polagruto JA, Lee L, Holt RR, Schrader HR, Ensunsa JL, Steinberg FM, Schmitz HH, Keen CL. Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholes-terolemic postmenopausal women. J Cardiovasc Pharmacol. 2006;47: S177-S186.
87. Hermann F, Spieker LE, Ruschitzka F, Sudano I, Hermann M, Binggeli C, Lüscher TF, Riesen W, Noll G, Corti R. Dark chocolate improves endothelial and platelet function. Heart. 2006;92:119-120.
88. Flammer AJ, Hermann F, Sudano I, Spieker L, Hermann M, Cooper KA, Serafini M, Lüscher TF, Ruschitzka F, Noll G, Corti R. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation. 2007;116:2376-2382.
89. Hamed MS, Gambert S, Bliden KP, Bailon O, Anand S, Antonino MJ, Hamed F, Tantry US, Gurbel PA. Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. South Med J. 2008;101:1203-1208.
90. Duffy SJ, Vita JA, Holbrook M, Swerdloff PL, Keaney JF Jr. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21: 1084-1089. (Pubitemid 34168673)
91. Hodgson JM, Puddey IB, Mori TA, Burke V, Baker RI, Beilin LJ. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur J Clin Nutr. 2001;55:881-886.
92. Hodgson JM, Puddey IB, Burke V, Beilin LJ, Mori TA, Chan SY. Acute effects of ingestion of black tea on postprandial platelet aggregation in human subjects. Br J Nutr. 2002;87:141-145.
93. Wolfram RM, Oguogho A, Efthimiou Y, Budinsky AC, Sinzinger H. Effect of black tea on (iso-) prostaglandins and platelet aggregation in healthy volunteers. Prostaglandins Leukot Essent Fatty Acids. 2002;66: 529-533.
94. Steptoe A, Gibson EL, Vuononvirta R, Hamer M, Wardle J, Rycroft JA, Martin JF, Erusalimsky JD. The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis. 2007;193:277-282.
95. Hirano-Ohmori R, Takahashi R, Momiyama Y, Taniguchi H, Yonemura A, Tamai S, Umegaki K, Nakamura H, Kondo K, Ohsuzu F. Green tea consumption and serum malondialdehyde-modified LDL concentrations in healthy subjects. J Am Coll Nutr. 2005;24:342-346.
96. Lee W, Min WK, Chun S, Lee YW, Park H, Lee DH, Lee YK, Son JE. Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin Biochem. 2005;38:84-87. (Pubitemid 39647660)
97. Bordia A, Verma SK, Srivastava KC. Effect of garlic on platelet aggregation in humans: a study in healthy subjects and patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids. 1996;55: 201-205.
98. Rahman K, Billington D. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J Nutr. 2000;130:2662-2665.
99. Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC, Katan MB. Effects of the flavonoids quercetin and apigenin on hemo-stasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr. 1998;67:255-262
100. O'Kennedy N, Crosbie L, Whelan S, Luther V, Horgan G, Broom JI, Webb DJ, Duttaroy AK. Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr. 2006;84:561-569.
101. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost. 2004;2:2138-2145.
102. Pignatelli P, Di Santo S, Buchetti B, Sanguigni V, Brunelli A, Violi F. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment. FASEB J. 2006;20:1082-1089.
103. Wollny T, Chabielska E, Malinowska-Zaprzałka M, Nazarko J, Rozmysłowicz-Szermińska W, Buczko W. Effects of Bulgarian red and white wines on primary hemostasis and experimental thrombosis in rats. Pol J Pharmacol. 2003;55:1089-1096.
104. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994; 334:793-795.
105. Brigelius-Flohé R, Traber MG. Vitamin E: function and metabolism. FASEB J. 1999;13:1145-1155.
106. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361:2017-2023.
107. Violi F, Micheletta F, Iuliano L. How to select patient candidates for antioxidant treatment? Circulation. 2002;106:e195
108. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:23-33.
109. Violi F, Cangemi R. Antioxidant supplements and cardiovascular disease in men. JAMA. 2009;301:1335.
110. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330: 1029-1035.
111. Leppälä JM, Virtamo J, Fogelholm R, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol. 2000;20:230-235. (Pubitemid 30048369)
112. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300:2123-2133.
113. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005;294:56-65. (Pubitemid 41002839)
114. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med. 2007;167:1610-1618.
115. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-160.
116. Huijgens PC, van den Berg CA, Imandt LM, Langenhuijsen MM. Vitamin E and platelet aggregation. Acta Haematol. 1981;65:217-218.
117. Stampfer MJ, Jakubowski JA, Faigel D, Vaillancourt R, Deykin D. Vitamin E supplementation effect on human platelet function, arachi-donic acid metabolism, and plasma prostacyclin levels. Am J Clin Nutr. 1988;47:700-706.
118. Jandak J, Steiner M, Richardson PD. Alpha-tocopherol, an effective inhibitor of platelet adhesion. Blood. 1989;73:141-149.
119. Freedman JE, Li L, Sauter R, Keaney JF JR. Alpha-tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release. FASEB J. 2000;14:2377-2379.
120. Murohara T, Ikeda H, Otsuka Y, Aoki M, Haramaki N, Katoh A, Takajo Y, Imaizumi T. Inhibition of platelet adherence to mono-nuclear cells by alpha-tocopherol: role of P-selectin. Circulation. 2004;110:141-148.
121. Dereska NH, McLemore EC, Tessier DJ, Bash DS, Brophy CM. Short-term, moderate dosage vitamin E supplementation may have no effect on platelet aggregation, coagulation profile, and bleeding time in healthy individuals. J Surg Res. 2006;132:121-129.
122. Gisinger C, Jeremy J, Speiser P, Mikhailidis D, Dandona P, Schern-thaner G. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients: double-blind crossover trial. Diabetes. 1988;37:1260-1264.
123. Jain SK, Krueger KS, McVie R, Jaramillo JJ, Palmer M, Smith T. Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients. Diabetes Care. 1998;21: 1511-1516.
124. Davì G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99: 224-229.
125. Clarke MW, Ward NC, Wu JH, Hodgson JM, Puddey IB, Croft KD. Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes. Am J Clin Nutr. 2006;83:95-102.
126. Vignini A, Nanetti L, Moroni C, Testa R, Sirolla C, Marra M, Manfrini S, Fumelli D, Marcheselli F, Mazzanti L, Rabini RA. A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2008;18:15-22.
127. Patrignani P, Panara MR, Tacconelli S, Seta F, Bucciarelli T, Ciabattoni G, Alessandrini P, Mezzetti A, Santini G, Sciulli MG, Cipollone F, Davì G, Gallina P, Bon GB, Patrono C. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation. 2000;102:539-545.
128. Williams JC, Forster LA, Tull SP, Wong M, Bevan RJ, Ferns GA. Dietary vitamin E supplementation inhibits thrombin-induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercho-lesterolaemia. Int J Exp Pathol. 1997;78:259-266.
129. Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation. 2007;116:1497-1503.
130. Violi F, Pignatelli P. Letter by Violi and Pignatelli regarding article, "Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study." Circulation. 2008;117:e312.
131. Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, Chen S, Corpe C, Dutta A, Dutta SK, Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003;22:18-35. (Pubitemid 36164454)
132. Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol. 2008;28:s11-s16.
133. Pignatelli P, Sanguigni V, Paola SG, Lo Coco E, Lenti L, Violi F. Vitamin C inhibits platelet expression of CD40 ligand. Free Radic Biol Med. 2005;38:1662-1666.
134. Wilkinson IB, Megson IL, MacCallum H, Sogo N, Cockcroft JR, Webb DJ. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol. 1999;34:690-693.
135. Ellis GR, Anderson RA, Chirkov YY, Morris-Thurgood J, Jackson SK, Lewis MJ, Horowitz JD, Frenneaux MP. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol. 2001;37: 564-570.
136. Morel O, Jesel L, Hugel B, Douchet MP, Zupan M, Chauvin M, Freyssinet JM, Toti F. Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles. J Thromb Haemost. 2003;1:171-177.
137. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533-537.
138. Salonen JT, Salonen R, Seppänen K, Rinta-Kiikka S, Kuukka M, Korpela H, Alfthan G, Kantola M, Schalch W. Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status. Am J Clin Nutr. 1991;53:1222-1229.
139. Calzada C, Bruckdorfer KR, Rice-Evans CA. The influence of anti-oxidant nutrients on platelet function in healthy volunteers. Atherosclerosis. 1997;128:97-105.
140. Mensink RP, van Houwelingen AC, Kromhout D, Hornstra G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr. 1999;69:213-219.
141. Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr. 2003;77:700-706.
142. Accinni R, Rosina M, Bamonti F, Della Noce C, Tonini A, Bernacchi F, Campolo J, Caruso R, Novembrino C, Ghersi L, Lonati S, Grossi S, Ippolito S, Lorenzano E, Ciani A, Gorini M. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis. 2006;16:121-127.
143. Schoene NW, Chanmugam P, Reynolds RD. Effect of oral vitamin B6 supplementation on in vitro platelet aggregation. Am J Clin Nutr. 1986; 43:825-830.
144. van Wyk V, Luus HG, Heyns AD. The in vivo effect in humans of pyridoxal-5'-phosphate on platelet function and blood coagulation. Thromb Res. 1992;66:657-668.
145. Clarke R, Harrison G, Richards S, for the Vital Trial Collaborative Group. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med. 2003;254:67-75.